Patent ID: 11865161
Assignee: HAMLET PHARMA AB
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 9:
10. A method for preventing formation of a colon cancer, wherein the method comprises administering to an individual that does not have colon cancer a biologically active complex comprising alpha-lactalbumin or a variant thereof or a peptide of up to 50 amino acids comprising SEQ ID NO: 3 or 5 and a fatty acid or a salt thereof, wherein:
i) the alpha-lactalbumin is human alpha-lactalbumin and the biologically active complex is HAMLET; or
ii) the alpha-lactalbumin is bovine alpha-lactalbumin and the biologically active complex is BAMLET; and
iii) the variant is a variant of native mature alpha-lactalbumin wherein all of the cysteines have been mutated to other amino acids.